A Novel Digital Behavioral Therapy Reduces Fibromyalgia Severity: Results of the PROSPER-FM RCT

We report the effectiveness of FM-ACT from PROSPER-FM (NCT05243511), a pivotal randomized controlled trial (RCT). The trial randomized 275 participants with FM to receive 12 weeks of FM-ACT or an active comparator (Symptom Tracker (ST), designed as a daily symptom tracker/monitor with access to patient education materials).

Source: The Journal of Pain - April 1, 2024 Category: Materials Science Authors: Dianne M. Shumay, R. Michael Gendreau, Andrea L. Chadwick, Lance M. McCracken, David A. Williams, Daniel J. Clauw, Juan V. Luciano, Yifei Dai, Nicolette Vega, Zunera Ghalib, Kristen Guthrie, Allison C. Kraus, Michael J Rosenbluth, Lesley M. Arnold Tags: Psychosocial Factors and Interventions Source Type: research